RE: Independent analysis25 Sep 2022 17:34
We can all remember what you have previous posted Captain, absolute disgrace that you continually try your best to make any poster out to be a liar and that anything which is posted you turn everything around. I posted that the overdraft facility was not needed as it wasn't being used. The fact that it was withdrawn is nothing to do with the bank thinking that the company couldn't repay it. It simply wasn't renewed. The fact that the CD4 test was sold, is that it was making a loss as ODX had stopped work on other parts of company and had concentrated on covid. The government let the contract run out without giving ODX a test to produce.
Not ODX 's fault. So to turn around a £5m + loss making company into one which has stopped those losses and can now go forward with a business, (which showed an increase in growth last year), when previous Concentrating on government contract which didn't work out.
New premises to move in to, money in bank, more money to come, good product which will be used all the more now.